Serge Benichou

Dr. Serge Benichou

Institut Cochin, Inserm, CNRS, University of Paris
orcid

Research Focus & Metrics

Academic Career Length

36Years (1991-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 1998 in Molecular Cell
Verified
Journal Article
Closed access
FMFlorence Margottin
Florence Margottin
SBStephan P Bour
Stephan P Bour
HDHervé Durand
Hervé Durand
LSLuc Selig
Luc Selig
Serge BenichouSerge Benichou
Serge Benichou
RBRichard Benarous
Richard Benarous

1 April 1998 in Immunity
Verified
Journal Article
Closed access
SGSylvie Le Gall
Sylvie Le Gall
LELars Erdtmann
Lars Erdtmann
Serge BenichouSerge Benichou
Serge Benichou
CBClarisse Berlioz-Torrent
Clarisse Berlioz-Torrent
LLLangxia Liu
Langxia Liu
OSOlivier Schwartz
Olivier Schwartz

1 October 2002 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
MSMark G.H. Scott
Mark G.H. Scott
ERErwann Le Rouzic
Erwann Le Rouzic
APAxel Périanin
Axel Périanin
VPVincenzo Pierotti
Vincenzo Pierotti
HEHervé Enslen
Hervé Enslen
ABAlexandre Benmerah
Alexandre Benmerah
β-arrestins (βarrs) are two highly homologous proteins that uncouple G protein-coupled receptors from their cognate G proteins, serve as adaptor molecules linking G protein-coupled receptors to clathrin-coat components (AP-2 complex and clathrin), and act as scaffolding proteins for ERK1/2 and JNK3 cascades. A striking difference between the two βarrs (βarr1 and βarr2) is that βarr1 is evenly distributed throughout the cell, whereas βarr2 shows an apparent cytoplasmic localization at steady state. Here, we investigate the molecular determinants underlying this differential distribution. βarr2 is constitutively excluded from the nucleus by a leptomycin B-sensitive pathway because of the presence of a classical leucine-rich nuclear export signal in its C terminus (L395/L397) that is absent in βarr1. In addition, using a nuclear import assay in yeast we showed that βarr2 is actively imported into the nucleus, suggesting that βarr2 undergoes constitutive nucleocytoplasmic shuttling. In cells expressing βarr2, JNK3 is mostly cytosolic. A point mutation of the nuclear export signal (L395A) in βarr2, which was sufficient to redistribute βarr2 from the cytosol to the nucleus, also caused the nuclear relocalization of JNK3. These data indicate that the nucleocytoplasmic shuttling of βarr2 controls the subcellular distribution of JNK3.

19 February 2018 in Frontiers in Immunology
Verified
Journal Article
Open access
PDF file
LBLucie Bracq
Lucie Bracq
MXMaorong Xie
Maorong Xie
Serge BenichouSerge Benichou
Serge Benichou
JBJérôme Bouchet
Jérôme Bouchet
While HIV-1 infection of target cells with cell-free viral particles has been largely documented, intercellular transmission through direct cell-to-cell contact may be a predominant mode of propagation in host. To spread, HIV-1 infects cells of the immune system and takes advantage of their specific particularities and functions. Subversion of intercellular communication allows to improve HIV-1 replication through a multiplicity of intercellular structures and membrane protrusions, like tunneling nanotubes, filopodia, or lamellipodia-like structures involved in the formation of the virological synapse. Other features of immune cells, like the immunological synapse or the phagocytosis of infected cells are hijacked by HIV-1 and used as gateways to infect target cells. Finally, HIV-1 reuses its fusogenic capacity to provoke fusion between infected donor cells and target cells, and to form infected syncytia with high capacity of viral production and improved capacities of motility or survival. All these modes of cell-to-cell transfer are now considered as viral mechanisms to escape immune system and antiretroviral therapies, and could be involved in the establishment of persistent virus reservoirs in different host tissues.

1 October 1997 in Structure
Verified
Journal Article
Closed access
SAStefan Arold
Stefan Arold
PFPeet Franken
Peet Franken
MSMarie-Paule Strub
Marie-Paule Strub
FHFrançois Hoh
François Hoh
Serge BenichouSerge Benichou
Serge Benichou
CDChristian Dumas
Christian Dumas

1 August 2000 in Journal of Virology
Verified
Journal Article
Open access
PDF file
LMLouis M. Mansky
Louis M. Mansky
SPSandra Preveral
Sandra Preveral
LSLuc Selig
Luc Selig
RBRichard Benarous
Richard Benarous
Serge BenichouSerge Benichou
Serge Benichou
The Vpr protein of human immunodeficiency virus type 1 (HIV-1) influences the in vivo mutation rate of the virus. Since Vpr interacts with a cellular protein implicated in the DNA repair process, uracil DNA glycosylase (UNG), we have explored the contribution of this interaction to the mutation rate of HIV-1. Single-amino-acid variants of Vpr were characterized for their differential UNG-binding properties and used to trans complement vpr null mutant HIV-1. A striking correlation was established between the abilities of Vpr to interact with UNG and to influence the HIV-1 mutation rate. We demonstrate that Vpr incorporation into virus particles is required to influence the in vivo mutation rate and to mediate virion packaging of the nuclear form of UNG. The recruitment of UNG into virions indicates a mechanism for how Vpr can influence reverse transcription accuracy. Our data suggest that distinct mechanisms evolved in primate and nonprimate lentiviruses to reconcile uracil misincorporation into lentiviral DNA.